IN
Amplia Therapeutics Limited
INNMF · OTC
$0.08 +6.31% (+$0.00)
1M -20.52%
Market Cap $60.2M
P/E Ratio -
Div. Yield -
ROE 22.61%
Piotroski F-Score Weak
1/9Valuation
35 /100
Fair P/S 15.90x
P/B 2.86x
P/E N/A
Growth
82 /100
Growing Rev. growth 24.02%
Book val. growth 1.27%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 94.43%
Net margin 173.69%
FCF margin 182.04%
Quality
2 /100
Poor ROIC 30.94%
ROE 22.61%
Asset turnover 0.16x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 7.91x
Int. coverage N/A
Stability
34 /100
Moderate Beta -0.40x
Rev. volatility 174.73%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o INNMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Burns
Employees
1
Headquarters
Melbourne
Nadchodzące wydarzenia
27 LIS
Earnings
Upcoming earnings report